(RTTNews) - Hoth Therapeutics, Inc. (HOTH) Tuesday announced positive preclinical results for HT-KIT, a novel targeted therapy for gastrointestinal stromal tumors (GIST). GIST is a rare but ...

Hoth Therapeutics announces positive preclinical results for HT-KIT in aggressive cancer gastrointestinal stromal tumours: New York Wednesday, March 19, 2025, 18:00 Hrs [IST] Hoth ...

Hoth Therapeutics (HOTH) announced breakthrough preclinical findings demonstrating the efficacy of HT-KIT, a novel targeted ...

A study shows that high-grade glioma tumor cells harboring DNA alterations in the gene PDGFRA responded to the drug avapritinib, which is already approved by the United States Food and Drug ...

A company presentation will take place during the conference's Innovation track on Friday, March 28th at 9:00am. NeauxCancer ...

which is already approved by the United States Food and Drug Administration to treat gastrointestinal stromal tumors ... Genetic Mutations Linked to Toxin Exposure Found in Firefighters' Brain ...

Continues focus on development of bispecific anti-cancer agents with differentiated mechanisms of action SEATTLE, WASHINGTON / ACCESS Newswire / March 18, 2025 / Aptevo Therapeutics , a leader in the ...

High-grade glioma, a difficult-to-treat and aggressive form of pediatric and adult brain cancer, responded to FDA-approved avapritinib. | Drug Discovery And Development ...

Apollo Health, a leading provider of clinically proven innovative health solutions for cognition, has partnered with Trifecta Nutrition, the nation's largest science-backed meal delivery service ...

We recently published a list of 10 Stocks Insiders Are Selling In March. In this article, we are going to take a look at ...

Learn more about whether Recursion Pharmaceuticals, Inc. or Zai Lab Limited is a better investment based on AAII's A+ ...

Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in Blueprint Medicines Co. (NASDAQ:BPMC – Free Report) by 17.1% ...